Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review

Sanghamitra Mohanty; Luigi Di Biase; Prasant Mohanty; Pasquale Santangeli; Bai Rong; Trivedy Chintan; David Burkhardt; Joseph G. Gallinghouse; Rodney Horton; Javier E. Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale

Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review

Sanghamitra Mohanty, Luigi Di Biase, Prasant Mohanty, Pasquale Santangeli, Bai Rong, Trivedy Chintan, David Burkhardt, Joseph G. Gallinghouse, Rodney Horton, Javier E. Sanchez, Shane Bailey, Jason Zagrodzky, Andrea Natale

Research output: Contribution to journal › Review article › peer-review

Abstract

Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-Ablation by effectively addressing the different constituents of MS.

Original language	English (US)
Pages (from-to)	28-36
Number of pages	9
Journal	Journal of Atrial Fibrillation
Volume	5
Issue number	5
State	Published - Feb 2013
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{9f4a125d4b1f4ab4bb4a5918ff94c025,

title = "Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review",

abstract = "Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-Ablation by effectively addressing the different constituents of MS.",

author = "Sanghamitra Mohanty and Biase, {Luigi Di} and Prasant Mohanty and Pasquale Santangeli and Bai Rong and Trivedy Chintan and David Burkhardt and Gallinghouse, {Joseph G.} and Rodney Horton and Sanchez, {Javier E.} and Shane Bailey and Jason Zagrodzky and Andrea Natale",

year = "2013",

month = feb,

language = "English (US)",

volume = "5",

pages = "28--36",

journal = "Journal of Atrial Fibrillation",

issn = "1941-6911",

publisher = "Cardiofront, Inc.",

number = "5",

}

TY - JOUR

T1 - Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation

T2 - A systematic review

AU - Mohanty, Sanghamitra

AU - Biase, Luigi Di

AU - Mohanty, Prasant

AU - Santangeli, Pasquale

AU - Rong, Bai

AU - Chintan, Trivedy

AU - Burkhardt, David

AU - Gallinghouse, Joseph G.

AU - Horton, Rodney

AU - Sanchez, Javier E.

AU - Bailey, Shane

AU - Zagrodzky, Jason

AU - Natale, Andrea

PY - 2013/2

Y1 - 2013/2

N2 - Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-Ablation by effectively addressing the different constituents of MS.

AB - Metabolic syndrome (MS), a pro-inflammatory state with hypertension, diabetes, dyslipidemia and obesity is presumed to be a close associate of atrial fibrillation (AF). However, the exact mechanism by which MS facilitates perpetuation of AF is yet to be fully understood. Moreover, the impact of the components of MS as well as MS as a group, on ablation-outcome in AF is not clearly elucidated until now. This review has compiled the results from major studies that have looked into those risk factors and defined their significance in influencing ablation-outcome in AF. It has also overviewed the impact of life-style changes that might improve the success rate of AF-Ablation by effectively addressing the different constituents of MS.

UR - http://www.scopus.com/inward/record.url?scp=84875495574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875495574&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84875495574

SN - 1941-6911

VL - 5

SP - 28

EP - 36

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

IS - 5

ER -

Impact of metabolic syndrome on ablation-outcome in patients with atrial fibrillation: A systematic review

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this